- Home
- MREO vs SNCY Comparison
MREO vs SNCY Comparison
Compare MREO & SNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- SNCY
- Stock Information
- Founded
- MREO 2015
- SNCY 1982
- Country
- MREO United Kingdom
- SNCY United States
- Employees
- MREO N/A
- SNCY N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- SNCY Air Freight/Delivery Services
- Sector
- MREO Health Care
- SNCY Consumer Discretionary
- Exchange
- MREO Nasdaq
- SNCY Nasdaq
- Market Cap
- MREO 577.6M
- SNCY 558.2M
- IPO Year
- MREO N/A
- SNCY 2021
- Fundamental
- Price
- MREO $3.68
- SNCY $13.91
- Analyst Decision
- MREO Strong Buy
- SNCY Buy
- Analyst Count
- MREO 4
- SNCY 6
- Target Price
- MREO $7.50
- SNCY $18.33
- AVG Volume (30 Days)
- MREO 769.7K
- SNCY 1.0M
- Earning Date
- MREO 11-12-2024
- SNCY 10-30-2024
- Dividend Yield
- MREO N/A
- SNCY N/A
- EPS Growth
- MREO N/A
- SNCY N/A
- EPS
- MREO N/A
- SNCY 0.82
- Revenue
- MREO $1,000,000.00
- SNCY $1,060,877,000.00
- Revenue This Year
- MREO $16.39
- SNCY $4.13
- Revenue Next Year
- MREO $9.44
- SNCY $8.33
- P/E Ratio
- MREO N/A
- SNCY $17.14
- Revenue Growth
- MREO N/A
- SNCY 2.87
- 52 Week Low
- MREO $1.86
- SNCY $9.22
- 52 Week High
- MREO $5.02
- SNCY $17.56
- Technical
- Relative Strength Index (RSI)
- MREO 39.84
- SNCY 51.12
- Support Level
- MREO $3.18
- SNCY $13.20
- Resistance Level
- MREO $4.40
- SNCY $15.92
- Average True Range (ATR)
- MREO 0.24
- SNCY 0.56
- MACD
- MREO -0.06
- SNCY -0.26
- Stochastic Oscillator
- MREO 41.39
- SNCY 26.10
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About SNCY Sun Country Airlines Holdings Inc.
Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.